Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2008
08/13/2008CN101239076A Blood plasma immunoregulation medicament capsule
08/13/2008CN101239075A Blood platelet aqueous products
08/13/2008CN101239070A Eyedrops for curing eye affection and uses thereof
08/13/2008CN101239066A Triamcinolone acetonide econazole cream
08/13/2008CN101239065A Method for preparing cefepime dihydrochloride and L-arginine mixed powder
08/13/2008CN101239063A Pharmaceutical compositions
08/13/2008CN101239052A Method for preparing sodium alginate/ chitosan sustained-release microcapsule by external gelation
08/13/2008CN101239050A Pentoxifylline sustained release tablets and preparation thereof
08/13/2008CN101239049A Hypnotic drugs zaleplon dispersible tablet and preparation thereof
08/13/2008CN101239048A Cyclosporine A fast release solid dosage forms and preparation thereof
08/13/2008CN101239046A Epalrestat dropping pills and preparation thereof
08/13/2008CN101239045A Atorvastatin dropping pills and preparation thereof
08/13/2008CN101239044A Solid composition
08/13/2008CN101239043A 5-fluorouracil self-emulsifying nano-scale freeze-dried powder and preparation thereof
08/13/2008CN101239042A Orally-administered solid composition shielded bitter
08/13/2008CN101239041A High molecule liposome and uses thereof
08/13/2008CN101239040A Celastrol liposome and preparation thereof
08/13/2008CN101239039A Establishing and evaluating method of self-emulsifying drug administration system common formula system
08/13/2008CN101239038A Aminoglucose injection and preparation thereof
08/13/2008CN101239037A Acetylcysteine injection and preparation thereof
08/13/2008CN101239035A Policresulen vaginal gel and preparation thereof
08/13/2008CN100409899C Application of pachyman as disintegrating agent in preparation of medicinal tablet
08/13/2008CN100409896C Senile dementia vaccinum and preparing method thereof
08/13/2008CN100409859C 'Fu Yan Jing' film for treating gynecological inflammation and preparation method thereof
08/13/2008CN100409843C Adhesive patch containing tulobuterol
08/13/2008CN100409841C Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration
08/13/2008CN100409759C Improved hard sugar coating method
08/12/2008US7412285 Method and device for treating cancer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy
08/12/2008US7411041 DCRS5 polypeptides
08/12/2008US7411031 Synthesis of polyanhydrides
08/12/2008US7411006 Add trisodium citrate to get cryoprecipitate without freezing plasma, without chromatography; single donors, limited pools; cryoprecipitate formed into a fibrin fabric; surgeries, wounds
08/12/2008US7410983 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
08/12/2008US7410957 Method of treatment using bisphosphonic acid
08/12/2008US7410947 Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
08/12/2008US7410943 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma
08/12/2008US7410799 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
08/12/2008US7410779 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
08/12/2008US7410699 Finely particulate composite containing carbon compound encapsulated in a polymer micelle of a block copolymer
08/12/2008US7410652 Controlled release and taste masking oral pharmaceutical composition
08/12/2008US7410651 Controlled release and taste masking oral pharmaceutical composition
08/12/2008US7410635 Aerosol formulations and aerosol delivery of scopolamine
08/12/2008CA2547866C Farnesyl dibenzodiazepinone formulation
08/12/2008CA2432037C Famotidine injection solution
08/12/2008CA2420461C Preparations for oral administration
08/12/2008CA2383570C Pourable liquid vehicles
08/12/2008CA2376236C Modification of biological elements
08/12/2008CA2375885C Water-thin emulsions with low emulsifier levels
08/12/2008CA2328080C Wettable microcapsules having hydrophobic polymer coated cores
08/12/2008CA2326048C Peroral active agent suspension
08/12/2008CA2320224C Method for modulating macrophage activation
08/12/2008CA2308660C Stable aqueous pharmaceutical composition comprising tezosentan
08/12/2008CA2304568C Olanzapine pamoate formulations
08/12/2008CA2257810C Skin wash composition comprising an .alpha.-hydroxy acid or other acid and a detergent base
08/12/2008CA2184828C Composition for inactivating irritants in fluids
08/07/2008WO2008094910A2 Hyaluronate compositions
08/07/2008WO2008094834A2 Multi-functional drug carriers
08/07/2008WO2008094693A2 Compositions for aerosolization of highly conductive solutions
08/07/2008WO2008094675A2 Novel biomaterials and methods for making and using same
08/07/2008WO2008094659A2 Novel biomaterials for ocular drug delivery and a method for making and using same
08/07/2008WO2008094144A1 Polymer-coated nanoparticles
08/07/2008WO2008093793A1 Agent for relief or prevention of xerostomia
08/07/2008WO2008093331A1 Antibody conjugates for circumventing multi-drug resistance
08/07/2008WO2008093221A2 Pharmaceutical compositions containing pde4 inhibitor for the treatment of inflammatory and allergic disorders
08/07/2008WO2008092812A1 Powders having a high content of edible oil and method for the production thereof
08/07/2008WO2008092396A1 Microcapsule formulation of kitasamycin, process for preparation thereof and use thereof
08/07/2008WO2008074804A3 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application
08/07/2008WO2008069012A3 Ejection liquid and ejection method
08/07/2008WO2008054585A9 Use of pegylated il-10 to treat cancer
08/07/2008WO2008051864A3 Method of treating spinal internal disk derangement
08/07/2008WO2008024006A3 Pharmaceutical preparation in a gel form
08/07/2008WO2007069274A3 Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
08/07/2008US20080188572 Imparting oxidation stability; exine shells of naturally occurring spores
08/07/2008US20080188571 Oral controlled release intercalation formulation using such as aluminum lithium hydroxide derivative; reducing stomach upset by providing antiacid effect
08/07/2008US20080188509 Transdermal Preparations and Method for Relieving Side Effects in Pergolide Therapy
08/07/2008US20080188422 Peptides having separate domains; AIDS, cardiovascular disease, hepatitis. diabetes, cancer; side effect reduction
08/07/2008US20080188416 Easily alterable or removable implants; producing desired structural change; treating wrinkles, aging effects, scars; such as polymethyl methacrylate matrix material with chondroitin sulfate
08/07/2008US20080188415 Composition of matter containing harmonized hydroxyl modified fullerene substance
08/07/2008US20080187981 Thermo-stable bio-matrix
08/07/2008US20080187968 For eukaryotic in vitro expression; silicone-based surfactants and microcapsules; phage display
08/07/2008US20080187612 Delivery Systems
08/07/2008US20080187588 Containing phosphodiesterase inhibitor vardensfil; erectile dysfunction
08/07/2008US20080187569 Dissolution of arterial plaque
08/07/2008US20080187568 Polymerization with precipitation of proteins for elution in physiological solution
08/07/2008US20080187553 Immunstimulating lipid formulation
08/07/2008US20080187551 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines
08/07/2008US20080187517 Use of Serum Albumin Binding Peptides Conjugates for the Preparation of a Medicament
08/07/2008US20080187493 Peptide-Based Compounds
08/07/2008DE102008013023A1 Preparation of octanoic acid glycerin esters, useful e.g. for producing a cosmetic, pharmaceutical or dermatological formulation, comprises reacting glycerin and octanoic acid without adding a catalyst
08/07/2008DE102008006855A1 Phosphate esters useful in cosmetic, pharmaceutical or dermatological compositions are derived from a monoalkyl polyether and a polyether diol
08/07/2008DE10132669B4 Pharmakologische Zubereitung aus einem nanopartikulären mesomorphen Polyelektrolyt-Lipid-Komplex und mindestens einem Wirkstoff Pharmacological preparation of a nanoparticulate mesomorphic polyelectrolyte-lipid complex and at least one active ingredient
08/07/2008CA2677253A1 Formulations of lipophilic bioactive molecules
08/07/2008CA2676979A1 Compositions for aerosolization of highly conductive solutions
08/07/2008CA2676919A1 Novel biomaterials for ocular drug delivery and a method for making and using same
08/07/2008CA2676912A1 Multi-functional drug carriers
08/07/2008CA2676841A1 Controlled release of actives in skin
08/07/2008CA2676820A1 Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
08/07/2008CA2675378A1 Chitosan-based colloidal particles for rna delivery
08/07/2008CA2651866A1 Sialoadhesin-related compositions and methods
08/06/2008EP1953136A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same
08/06/2008EP1952825A1 Nanometer targeted drug for magneto-thermotherapy of malignant tumors
1 ... 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 ... 1712